ProSomnus, Inc.
OSADelisted Apr 25, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001934064
ProSomnus, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Feb 16, 2024; 27 institutions reported holding it in 13F filings for Q1 2024, worth $894.9K in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 3:02 PM ET
Revenue flow, FY2023
Where the revenue went in FY2023, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2023: $24.1M (87.1% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2023 | FY2022 |
|---|---|---|
| Period end | Dec 31, 2023 | Dec 31, 2022 |
| Filing | 10-K | 10-K |
| Reported | Mar 26, 2024 | Feb 1, 2023 |
| Revenue | $27.7M | $19.4M |
| Cost of revenue | $13.6M | $9.13M |
| Gross profit | – | $10.3M |
| Operating expenses | – | $21.7M |
| Research and development | $4.80M | $2.98M |
| Selling, general and administrative | $15.2M | $9.89M |
| Operating income | -$19.1M | -$11.5M |
| Interest expense | $5.38M | $6.12M |
| Income tax | $0 | – |
| Net income | -$24.1M | -$7.15M |
| EPS, basic | $-1.49 | $-0.71 |
| EPS, diluted | $-1.49 | $-0.71 |
| Weighted shares, basic | 16.2M | 10.0M |
| Weighted shares, diluted | 16.2M | 10.0M |
| Margins and growth | ||
| Gross margin | – | 52.9% |
| Operating margin | -69.1% | -59.2% |
| Net margin | -87.1% | -36.8% |
| Revenue growth, year over year | +42.6% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2023! | FY2022 |
|---|---|---|
| Period end | Dec 31, 2023 | Dec 31, 2022 |
| Filing | 10-K | 10-K |
| Reported | Mar 26, 2024 | Feb 1, 2023 |
| Cash and equivalents | $6.36M | $15.9M |
| Accounts receivable | $3.84M | $2.84M |
| Inventory | $2.04M | $639.9K |
| Total current assets | $14.3M | $21.2M |
| Property, plant and equipment | $3.36M | $2.40M |
| Total assets | $26.3M | $33.2M |
| Accounts payable | $4.05M | $2.10M |
| Short-term debt | $57.0K | $59.0K |
| Total current liabilities | $14.3M | $7.09M |
| Long-term debt | $129.0K | $185.6K |
| Total liabilities | $52.9M | $53.7M |
| Shareholders' equity | -$38.2M | -$20.5M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2023 | FY2022 |
|---|---|---|
| Period end | Dec 31, 2023 | Dec 31, 2022 |
| Filing | 10-K | 10-K |
| Reported | Mar 26, 2024 | Feb 1, 2023 |
| Operating cash flow | -$16.1M | -$10.2M |
| Capital expenditures | $1.47M | $1.35M |
| Free cash flow | -$17.6M | -$11.6M |
| Stock-based compensation | $1.18M | $2.16M |
| Investing cash flow | -$1.47M | -$1.35M |
| Financing cash flow | $8.74M | $26.0M |
| Ratio | ||
| Stock-based compensation, % of revenue | 4.3% | 11.1% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.